Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
optical   crawled time : 00:20    save search
Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023
Published: 2023-11-04 (Crawled : 00:20) - globenewswire.com
ADVM | News | $11.0 60K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
biotechnologies extension study
Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile from Single Intravitreal Injection of ADVM-022 in Wet AMD Patients Who Previously Required Frequent Anti-VEGF Injections
Published: 2021-10-01 (Crawled : 00:20) - biospace.com/
ADVM | News | $11.0 60K twitter stocktwits trandingview |
Health Technology
 | | O: 0.92% H: 0.0% C: 0.0%
injection
Gainers vs Losers
55% 45%

Top 10 Gainers
CZOO | $10.52 110.82% 10M twitter stocktwits trandingview |

CSSE 4 | $0.3181 108.86% 170M twitter stocktwits trandingview |
Consumer Services
BOF | $1.88 60.68% 98M twitter stocktwits trandingview |

AMST | $3.1 55.0% 66M twitter stocktwits trandingview |
Technology Services
LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.03 41.99% 15M twitter stocktwits trandingview |
Technology Services
MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information
RILY | $28.605 31.7% 9.9M twitter stocktwits trandingview |
Finance
RBBN 4 | $3.305 28.6% 1.9M twitter stocktwits trandingview |
Electronic Technology
RCAT | $1.53 27.5% 2.9M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.